Issue 4/2022

Non-metabolic functions of pyruvate kinase M2: PKM2 in tumorigenesis and therapy resistance (747 — 754)

 Mustafa İlhan

DOI: 10.4149/neo_2022_220119N77

Endothelial lipase promotes acute myeloid leukemia progression through metabolic reprogramming (755 — 763)

Si-Qi Shang, Ying Yang, Xue-Jiao Yang, Xiao-Dong Shi, Yun-Shuo Chen,  Yue-Ying Wang

DOI: 10.4149/neo_2022_211004N1408

miR-520d-3p/MIG-7 axis regulates vasculogenic mimicry formation and metastasis in osteosarcoma (764 — 775)

 Nan Yao, Jing Zhou, Jie Song, Yantao Jiang, Jian Zhang

DOI: 10.4149/neo_2022_211128N1683

Solute carrier organic anion transporter family member 4A1 promotes colorectal cancer progression and is regulated by miR-1224-5p (776 — 784)

Yan Jiang, Xizhen Zhou, Yingying Li,  Xiaojie Gao

DOI: 10.4149/neo_2022_211230N1854

Alleviation of neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma and its relationship with expression and changes of PD-L1 (785 — 793)

Ye-Han Zhou, Jia-Yu Li, Jia-Xin Yan, Peng Guo, Wen-Wu He,  Yang Liu

DOI: 10.4149/neo_2022_211223N1826

Methylation-mediated expression of SPARC is correlated with tumor progression and poor prognosis of breast cancer (794 — 806)

Xiao-Long Li, Jia-Li Li, Dong-Jie Qiu,  Li Ma

DOI: 10.4149/neo_2022_211002N1401

Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway (807 — 819)

Min Yuan, Xian-Ling Guo, Jian-Hua Chen, Yang He, Zhu-Qing Liu, He-Ping Zhang, Jie Ren,  Qing Xu

DOI: 10.4149/neo_2022_211012N1441

The oncogenic miR-27a/BTG2 axis promotes obesity-associated hepatocellular carcinoma by mediating mitochondrial dysfunction (820 — 831)

Qi Su, Zi-Xin Xu, Min-Li Xiong, Hui-Yi Li,  Ming-Yi Xu,  Sheng-Zheng Luo

DOI: 10.4149/neo_2022_211227N1837

LIMD2 promotes tumor proliferation, invasion, and epithelial-mesenchymal transition in clear cell renal cell carcinoma (832 — 840)

Qi-Yu Zhong, Ying-Wei Xie, Zhi-Liang Chen, Yu-Qing Chen, Yue-Xin Liu,  Wen-Lian Xie,  Wei Yan

DOI: 10.4149/neo_2022_211130N1701

The ETS1-LINC00278 negative feedback loop plays a role in COL4A1/COL4A2 regulation in laryngeal squamous cell carcinoma (841 — 858)

Chuan Yang, Huan Cao, Jian-Wang Yang, Jian-Tao Wang, Miao-Miao Yu,  Bao-Shan Wang

DOI: 10.4149/neo_2022_220310N263

TM4SF1 promotes glioma malignancy through multiple mechanisms (859 — 867)

Yan-Wen Zheng, Man Wang, Zhao-Min Zhong, Guo-Qing Wu, Ting Zhang, Li-Li Chen,  Ming Li

DOI: 10.4149/neo_2022_211009N1427

Cystathionine β-synthase expression correlates with tumor development and poor prognosis in lung squamous cell carcinoma patients (868 — 876)

Ya-Qing Han, Zi-Bo Zhang, Kun Wang, Guang-Jie Liu, Shao-Nan Xie, Qing-Yi Liu,  Fang Liu

DOI: 10.4149/neo_2022_211207N1745

Optimization of endometrial cancer organoids establishment by cancer-associated fibroblasts (877 — 885)

Yu-Liang Wu, Jia-Qing Li, Zubaidan Sulaiman, Qi Liu, Chun-Yan Wang,  Shu-Peng Liu,  Zheng-Liang Gao,  Zhong-Ping Cheng

DOI: 10.4149/neo_2022_211110N1597

The association of immune cell infiltration and prognostic value of tertiary lymphoid structures in gastric cancer (886 — 898)

Ji-Shang Yu, Wei-Bin Huang, Yu-Hui Zhang, Jian Chen, Jin Li, Hua-Feng Fu,  Zhe-Wei Wei,  Yu-Long He

DOI: 10.4149/neo_2022_220128N123

N-type calcium channel v2.2 is a target of TCF21 in adrenocortical carcinomas (899 — 908)

Barbara Passaia, Jean Kremer, Maria Candida Fragoso,  Claudimara Lotfi

DOI: 10.4149/neo_2022_220106N25

SIRT5 promotes non-small cell lung cancer progression by reducing FABP4 acetylation level (909 — 917)

 Zhen Li, Dong-Ping Yu, Ning Wang, Ting Tao, Wu Luo, Hui Chen

DOI: 10.4149/neo_2022_220107N28

LncRNA CRNDE is involved in radiation resistance in hepatocellular carcinoma via modulating the SP1/PDK1 axis (918 — 930)

 Kai-Yun Chen, Shu-Guang Zhu, Ji-Wen He, Xiao-Peng Duan

DOI: 10.4149/neo_2022_211230N1853

Abnormal expression and clinical significance of surface receptors on natural killer cells in the peripheral blood of patients with non-small cell lung cancer (931 — 939)

Peng-Cheng Liu, Xiao-Wen Feng, Xiao-Min Zhao, Jing Ye, Feng-Lian He, Hui Liu, Ren-Ming Li,  Xue-Fu Wang,  Da-Hai Zhao

DOI: 10.4149/neo_2022_220219N188

Silencing of B7-H4 induces intracellular oxidative stress and inhibits cell viability of breast cancer cells via downregulating PRDX3 (940 — 947)

Hao-Chuan Chen, Min Long, Zhao-Wei Gao, Chong Liu, Xia-Nan Wu, Lan Yang,  Ke Dong,  Hui-Zhong Zhang

DOI: 10.4149/neo_2022_220304N241

Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers (948 — 956)

 Mihaela Ilcheva, Petya Nikolova, Valeria Hadzhiyska, Kiril Mladenov

DOI: 10.4149/neo_2022_220203N135

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry (957 — 964)

Katarína Lešková, Peter Szépe, Tomáš Balhárek, Martina Barthová, Ľuboslava Janáková, Anna Farkašová,  Lukáš Plank

DOI: 10.4149/neo_2022_220318N300

NPM1 is a diagnostic and prognostic biomarker associated with the clinicopathological characteristics of gastric cancer (965 — 975)

Chang-An Guo, Xiao-Lu Su, Wen-Jie Wang, Tian-Hong Xia, Xiao-Meng Cao, Shao-Bin Yuan, Wen-An Wang, An Zhang,  Hong-Bin Liu

DOI: 10.4149/neo_2022_220303N237

Clinical outcomes of EGFR-TKIs in advanced squamous cell lung cancer (976 — 982)

Jin-Fei Si, Jing Xiang, Jing-Wen Wei, Yue Hao,  Zheng-Bo Song

DOI: 10.4149/neo_2022_220329N348

Late effects of childhood cancer recorded at a single outpatient clinic over the course of one year: implications for the follow-up care (983 — 992)

 Tomas Kepak, Hana Hrstkova, Viera Bajciova, Vitezslav Dusek, Marta Holikova, Lucie Strublova, Katerina Kepakova

DOI: 10.4149/neo_2022_220531N584